Sorry I was going to post the slides but, it states they are confidential and unathorized us of them is prohibited. Please check out the Broadcast to add your thoughts.
Points to note:
1. They are moving into various stages of trials for at least 4 products in 2008(Indaflex being the closest to market)
2. One of the 3 products for the "Top 10 Pharma" company is moving allong. Still don't name the company but, the product is ARX828 iNOS Inhibitor to help slow down and prevent Alzheimer's.
3. They expanded on the news earlier todya that the product Vansolin has a market of $150 per treatment day and and overall market of 3.6 Billion. In their studies so far it has shown to be very effective and safe. The current product has 80% of the market and is not as effective as their new product has shown at least in mice. Over the next year depending on what the human trials show they can do well with this product when it goes to market. They are trying to fast track it through the trials.
0 members recommend this.
